Introduction
Amiodarone (AMD) was originally introduced as an anti-anginal drug, but subsequently it was shown to possess an effective anti-arrhythmic property. 2 Currently, AMD is considered to be a Class III anti-arrhythmic drug and its use has been increasing in recent years for the treatment of resistant ventricular and supraventricular arrhythmia. 3'4 However, the clinical uses of this antiarrhythmic drug are severely limited due to manifestations of serious pulmonary complications which range from subacute necrotizing pneumonitis to pulmonary fibrosis [5] [6] [7] [8] as well as phospholipidosis. 9 Intratracheal (i.t.) instillation of AMD in hamsters as a single bolus induces pulmonary fibrosis which is initially characterized by interstitial pneumonitis that progresses to fibrosis. 1 16 The SOD activity in the supernatant was measured from the rate at which the autoxidation of adrenaline to its adrenochrome was inhibited. 17 The rate of adrenochrome forma- (Fig. 7A,B) . In contrast, lungs from hamsters in the saline + AMD group had lesions that ranged from multifocal proximal acinar interalveolar septal thickening and aggregations of airway inflammatory cells to multifocal fibrotic lesions that obliterated airspaces and showed abundant fibroblasts and collagen (Fig. 7C) 
